{"timestamp": 1771603585.817703, "value": {"ticker": "LCTX", "company_name": "Lineage Cell Therapeutics, Inc.", "short_name": "Lineage Cell Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 416731584, "float_shares": 171393630, "shares_outstanding": 230327537, "short_ratio": 24.43, "short_percent_of_float": 0.19510001, "shares_short": 25348081, "shares_short_prior": 24635130, "insider_percent_held": 0.053990003, "institution_percent_held": 0.44978002, "total_cash": 40486000, "total_debt": 2621000, "total_revenue": 10816000, "revenue_growth": -0.026, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -0.17983, "operating_margins": -1.02852, "debt_to_equity": 12.603, "current_ratio": 4.504, "book_value": 0.096, "price_to_book": 18.846874, "operating_cashflow": -20387000, "free_cashflow": -12063125, "price": 1.8093, "52w_high": 2.09, "52w_low": 0.37, "avg_volume": 1242776, "avg_volume_10d": 1402460, "full_time_employees": 70, "audit_risk": 3, "overall_risk": 2}}